Table 2.
Expression of inflammatory infiltrates in MS lesions and controls
Case no. (Age/Sex) | CD3 | CD4 | CD8 | CD68 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Lesion (no.) | Lesion type | Perivascular | Parenchymal | Perivascular | Parenchymal | Perivascular | Parenchymal | Perivascular | Parenchymal | |
1 (38/F) | Frontal plaques (3) | Acute | + | + | + | + | + | + | +++ | +++ |
NLWM | ++ | + | ++ | + | + | + | ++ | ++ | ||
NLGM | + | - | ++ | + | + | - | ++ | - | ||
2 (61/F) | Occipital plaques (3) | Ch. active | + | + | - | - | + | - | ++ | ++ |
NLWM | ++ | + | ++ | + | + | - | ++ | +++ | ||
NLGM | +++ | ++ | + | - | + | + | ++ | + | ||
3 (62/M) | Parietal plaques (3) | Ch. active | ++ | + | ND | ND | - | - | +++ | ++ |
NLWM | ++ | + | ND | ND | + | - | ++ | +++ | ||
NLGM | ++ | + | + | + | ++ | - | ++ | + | ||
4 (51/F) | Frontal plaques (3) | Acute | ++ | + | ND | ND | + | - | +++ | +++ |
NLWM | ++ | + | + | + | - | - | +++ | ++ | ||
NLGM | ND | ND | + | - | ND | ND | ++ | + | ||
5 (60/M) | Occipital plaques (3) | Acute | +++ | + | ND | ND | + | - | ++ | + |
NLWM | + | + | ++ | - | ++ | + | +++ | ++ | ||
NLGM | + | + | + | - | - | - | ++ | + | ||
6 (51,F) | Occipital plaques (3) | Acute | + | - | + | - | + | - | ++ | ++ |
NLWM | ++ | - | + | - | ++ | - | ++ | +++ | ||
NLGM | ++ | + | ++ | - | + | - | ++ | ++ | ||
7 (30, F) | Frontal plaques (3) | Acute | ++ | + | + | - | + | - | +++ | ++ |
NLGM | + | - | + | - | ++ | - | ++ | + | ||
8-12 | Normal (4) | Control WM | - | - | - | - | - | - | - | - |
Control GM | - | - | - | - | - | - | - | - |
F, female; M, male; NLWM, non-lesion white matter; NLGM, non-lesion gray matter. -, negative; +, slightly positive; ++, positive; +++, highly positive; ND, not determined; Ch. active, chronic active